热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　康龙化成（03759）公布，预计2024年实现营收约119.995亿-123.46亿元，同比增长4%-7%；归属于上市公司股东的净利润约17.29亿-18.57亿元，同比增长8%-16%；扣非净利约10.75亿-11.51亿元，同比下降24%-29%；经调整净利约15.61亿-16.56亿元，同比下降13%-18%。

　　伴随着全球生物医药行业投融资的初步复苏，公司第二季度、第三季度营业收入环比和同比均实现增长。同时，得益于CMC（小分子CDMO）服务项目按计划交付，公司第四季度营业收入同比进一步实现加速增长。按业绩预告中位值测算，公司第四季度营业收入环比增长4%、同比增长 13%。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.